Study of the Long-Term Safety of Pramlintide in Subjects With Type 1 Diabetes Mellitus

Completed · Phase 3

Conditions studied: Diabetes Mellitus, Type 1

In brief

This is a multicenter, open-label extension study designed to examine the long-term safety of pramlintide treatment in subjects with type 1 diabetes who have successfully completed treatment in the parent study 137-150.

Key facts

Study ID
NCT00107107
Run by
AstraZeneca
People needed
190
Starts
2002-11-01
Expected to finish
2005-06-01
Last updated by the study team
2015-09-23

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.